# Takeda Biopharmaceuticals India

Type: Company (TYO:4502)

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/takeda-biopharmaceuticals-india
Canonical HTML page: https://gethealthbrief.com/entity/takeda-biopharmaceuticals-india

## Recent coverage (1 stories)

### India OKs First Dengue Shot: QDENGA Targets 33% of Global Burden
2026-07-25 04:23:24 · Sentiment: Very Bullish · Impact: 7/10 · Sources: 2

DCGI's authorization of QDENGA brings India its first dengue vaccine, a no‑screening option that could reshape public health strategy. With the country bearing a third of the world's dengue cases, the vaccine promises to reduce hospitalizations and ease endemic pressure on healthcare systems.
Full story: https://gethealthbrief.com/story/india-qdenga-dengue-vaccine-approval-health-impact

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.